Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|December 11, 2008
Analysis of receptor tyrosine kinase internalization using flow cytometryNing Li, Kristen S Hill, Lisa A ElferinkMolecular Cancer Research : MCR|November 1, 2013
PKCι maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesisYin Wang, Kristen S Hill, Alan P FieldsJournal of Experimental Therapeutics & Oncology|January 13, 2011
Altered down regulation of the receptor tyrosine kinase met in pancreatic adenocarcinoma cellsKristen S Hill, Marta Lorinczi, Lisa A ElferinkMaternal and Child Health Journal|September 28, 2007
Unmet need among children with special health care needs in MassachusettsKristen S Hill, Linda C Freeman, Recai M Yucel, et al.Maternal and Child Health Journal|November 27, 2008
The well-being of parental caregivers of children with activity limitationsKaren Kuhlthau, Robert Kahn, Kristen S Hill, et al.Scientific Reports|December 16, 2023
Artesunate acts through cytochrome c to inhibit growth of pediatric AML cellsKristen S Hill, Erin E Schuler, Sally R Ellingson, et al.Genomics|May 15, 2007
Gene identification and evidence for expression of G protein alpha subunits, phospholipase C, and an inositol 1,4,5-trisphosphate receptor in Aplysia californica rhinophoreScott F Cummins, Melissa R De Vries, Kristen S Hill, et al.Cancers|April 13, 2024
Antineoplastic Drug Synergy of Artesunate with Navitoclax in Models of High-Grade Serous Ovarian CancerJ Robert McCorkle, Rebecca Ahn, Connie D Cao, et al.The Journal of Biological Chemistry|November 8, 2008
Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Listeria invasion protein internalin BXiu Gao, Marta Lorinczi, Kristen S Hill, et al.Cancers|April 30, 2021
KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung CancerKristen S Hill, Anthony McDowell, J Robert McCorkle, et al.Pageof 3